Literature DB >> 15608682

Mutually antagonistic actions of S100A4 and S100A1 on normal and metastatic phenotypes.

Guozheng Wang1, Shu Zhang, David G Fernig, Marisa Martin-Fernandez, Philip S Rudland, Roger Barraclough.   

Abstract

Increased levels of the homodimeric calcium-binding protein, S100A4, have been shown to cause a metastatic phenotype in at least three independent model systems of breast cancer and its presence in carcinoma cells has been shown to be associated with a reduction in the survival of patients suffering from a range of different cancers. S100A4 has been shown to interact in vitro with another member of the S100 family of proteins, S100A1. The purpose of the present study was to find out whether S100A1 could affect S100A4 function. Fluorescence resonance energy transfer was used to show the interaction of S100A4 and S100A1 in living cells and the binding affinities between S100A4 and S100A1 were determined using a biosensor. S100A1 reduced the S100A4 inhibition of nonmuscle myosin A self-association and phosphorylation in vitro. S100A1 reduced S100A4 induced motility and growth in soft agar and metastasis in vivo. The results show for the first time that interactions between different S100 proteins can affect cancer-related activity, and that the presence of S100A1 protein in carcinoma cells might modulate the effect of S100A4 on their metastatic abilities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15608682     DOI: 10.1038/sj.onc.1208291

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  S100P dissociates myosin IIA filaments and focal adhesion sites to reduce cell adhesion and enhance cell migration.

Authors:  Min Du; Guozheng Wang; Thamir M Ismail; Stephane Gross; David G Fernig; Roger Barraclough; Philip S Rudland
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

2.  Self-association of calcium-binding protein S100A4 and metastasis.

Authors:  Thamir M Ismail; Shu Zhang; David G Fernig; Stephane Gross; Marisa L Martin-Fernandez; Violaine See; Kaeko Tozawa; Christopher J Tynan; Guozheng Wang; Mark C Wilkinson; Philip S Rudland; Roger Barraclough
Journal:  J Biol Chem       Date:  2009-11-16       Impact factor: 5.157

3.  Design of high-affinity S100-target hybrid proteins.

Authors:  Atoosa Rezvanpour; Jeremy M Phillips; Gary S Shaw
Journal:  Protein Sci       Date:  2009-12       Impact factor: 6.725

4.  X-ray crystal structure of human calcium-bound S100A1.

Authors:  Zephan Melville; Ehson Aligholizadeh; Laura E McKnight; Dylan J Weber; Edwin Pozharski; David J Weber
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-03-22       Impact factor: 1.056

Review 5.  Calcium-dependent and -independent interactions of the S100 protein family.

Authors:  Liliana Santamaria-Kisiel; Anne C Rintala-Dempsey; Gary S Shaw
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

Review 6.  S100 proteins in cancer.

Authors:  Anne R Bresnick; David J Weber; Danna B Zimmer
Journal:  Nat Rev Cancer       Date:  2015-02       Impact factor: 60.716

7.  Large-scale proteomic identification of S100 proteins in breast cancer tissues.

Authors:  Patrizia Cancemi; Gianluca Di Cara; Nadia Ninfa Albanese; Francesca Costantini; Maria Rita Marabeti; Rosa Musso; Carmelo Lupo; Elena Roz; Ida Pucci-Minafra
Journal:  BMC Cancer       Date:  2010-09-03       Impact factor: 4.430

Review 8.  S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?

Authors:  Mikael Schneider; Jakob L Hansen; Søren P Sheikh
Journal:  J Mol Med (Berl)       Date:  2008-03-06       Impact factor: 4.599

Review 9.  Joining S100 proteins and migration: for better or for worse, in sickness and in health.

Authors:  Stephane R Gross; Connie Goh Then Sin; Roger Barraclough; Philip S Rudland
Journal:  Cell Mol Life Sci       Date:  2013-06-30       Impact factor: 9.261

10.  The role of TG2 in regulating S100A4-mediated mammary tumour cell migration.

Authors:  Zhuo Wang; Martin Griffin
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.